Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
If you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday.
Giovanni Pellegrini
affiliation not provided to SSRN
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
55
SSRN CITATIONS
0
CROSSREF CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
PCSK9
rs11591147 R46L Loss-of-Function Variant Protects Against Liver Damage in Individuals with NAFLD
Number of pages: 34
Posted: 19 May 2020
Stefania Grimaudo
,
Stefano Bartesaghi
,
Raffaela Rametta
,
Fabio Della Marra
,
Rosellina Margherita Mancina
,
Jussi Pihlajamäki
,
Dorota Kakol-Palm
,
Anne-Christine Andréasson
,
Paola Dongiovanni
,
Anna Ludovica Fracanzani
,
Giulia Lori
,
Ville Männistö
, Giovanni Pellegrini,
Mohammad Bohlooly-Y
,
Grazia Pennisi
,
Rosaria Maria Pipitone
,
Rocco Spagnuolo
,
Antonio Craxì
,
Daniel Lindén
,
Luca Valenti
,
Stefano Romeo
and
Salvatore Petta
University of Palermo - Section of Gastroenterology and Hepatology, AstraZeneca Pharmaceuticals - Bioscience Metabolism, Research and Early Development Cardiovascular, Renal and Metabolism (CVRM), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Parma - Dipartimento di Economia, University of Gothenburg - Department of Molecular and Clinical Medicine, University of Eastern Finland - Department of Clinical Nutrition, AstraZeneca Pharmaceuticals - Bioscience Metabolism, Research and Early Development Cardiovascular, Renal and Metabolism (CVRM), AstraZeneca Pharmaceuticals - Bioscience Cardiovascular, Research and Early Development Cardiovascular, Renal and Metabolism, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico - General Medicine and Metabolic Diseases, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Florence - Department of Experimental and Clinical Medicine, University of Eastern Finland - Department of Medicine,
affiliation not provided to SSRN
, AstraZeneca Pharmaceuticals - IMED Biotech Unit, University of Palermo - Section of Gastroenterology and Hepatology, University of Palermo - Biomedical Department of Internal and Specialized Medicine (DI.BI.M.I.S.), Magna Graecia University of Catanzaro - Department of Experimental and Clinical Medicine, University of Palermo - Section of Gastroenterology and Hepatology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico - General Medicine and Metabolic Diseases, University of Milan - Department of Pathophysiology and Transplantation, University of Gothenburg - Department of Molecular and Clinical Medicine and University of Palermo - Section of Gastroenterology and Hepatology
Downloads
55
(675,679)
View PDF
Download
Abstract:
NASH, NAFLD, FIBROSIS, PCSK9
Feedback